01.08.2000
A Phase II Trial of Etoposide, Leucovorin, 5-FU, and Interferon Alpha 2b (ELFI) + G-CSF for Patients with Pancreatic Adenocarcinoma: a Southwest Oncology Group Study (SWOG 9413)
Erschienen in: Investigational New Drugs | Ausgabe 3/2000
Einloggen, um Zugang zu erhalten